Literature DB >> 33560086

Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.

La'Kita M J Knight1, Allison A King2, John J Strouse1, Paula Tanabe1.   

Abstract

INTRODUCTION: Sickle cell disease (SCD) is the most common abnormal genetic blood disease that affects ∼100,000 Americans. Approximately 20% to 37% of children with sickle cell anemia have silent cerebral infarcts by the age of 14 years old. Neurocognitive deficits are identified in infants and preschool children with SCD. The purpose of this systematic literature review is to provide a comprehensive understanding of the prevalence, severity, and the associated risk factors for neurodevelopmental delays (NDDs) in children with SCD 5 years of age and younger.
METHODS: Systematic search of 6 databases identified 2467 potentially relevant publications and 8 were identified through a manual search. Only 24 articles met the inclusion criteria.
RESULTS: We identified an increased prevalence of NDDs (cognitive, motor, or both). Children experienced deficits with language, attention and behavior, executive functioning, school readiness and/or academic performance, and motor skills (fine and gross motor functioning). Risk factors include silent cerebral infarcts and strokes, SCD genotype (HbSS>HbSC), other biologic, and social factors.
CONCLUSION: NDDs are common in children ages 0 to 5 years old with SCD. There is an opportunity to improve adherence to national guideline recommendations and early detection practices by pediatricians, hematologists, and other health care providers.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33560086      PMCID: PMC8254873          DOI: 10.1097/MPH.0000000000002091

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  44 in total

1.  Neurodevelopmental deficits among infants and toddlers with sickle cell disease.

Authors:  Penny Glass; Tara Brennan; Jichuan Wang; Lori Luchtman-Jones; Lewis Hsu; Christen M Bass; Sohail Rana; Brenda Martin; Caroline Reed; Yao Iris Cheng; Victor Gordeuk
Journal:  J Dev Behav Pediatr       Date:  2013 Jul-Aug       Impact factor: 2.225

2.  Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke.

Authors:  Maria I Cancio; Kathleen J Helton; Jane E Schreiber; Matthew P Smeltzer; Guolian Kang; Winfred C Wang
Journal:  Br J Haematol       Date:  2015-06-07       Impact factor: 6.998

3.  Kindergarten readiness skills in children with sickle cell disease: evidence of early neurocognitive damage?

Authors:  R Grant Steen; X Joan Hu; Vanessa E Elliott; Mark A Miles; Shalita Jones; Winfred C Wang
Journal:  J Child Neurol       Date:  2002-02       Impact factor: 1.987

4.  Factors Influencing the Academic Performance of Children with Sickle Cell Anaemia in Ekiti, South West Nigeria.

Authors:  Oladele Simeon Olatunya; Oluwasola Julius Oke; Bankole Peter Kuti; Iyiade Adeseye Ajayi; Oyebanji Olajuyin; Olubunmi Omotosho-Olagoke; Adekunle Bamidele Taiwo; Opeyemi Ayodeji Faboya; Ayodeji Ajibola
Journal:  J Trop Pediatr       Date:  2018-02-01       Impact factor: 1.165

Review 5.  The cognitive and academic impact of sickle cell disease.

Authors:  Sara Day; Elisabeth Chismark
Journal:  J Sch Nurs       Date:  2006-12       Impact factor: 2.835

6.  Deficiencies in school readiness skills of children with sickle cell anemia: a preliminary report.

Authors:  C Chua-Lim; R B Moore; G McCleary; A Shah; V N Mankad
Journal:  South Med J       Date:  1993-04       Impact factor: 0.954

Review 7.  Need for cognitive rehabilitation for children with sickle cell disease and strokes.

Authors:  Allison A King; Michael R DeBaun; Desiree A White
Journal:  Expert Rev Neurother       Date:  2008-02       Impact factor: 4.618

8.  Stroke in a cohort of patients with homozygous sickle cell disease.

Authors:  B Balkaran; G Char; J S Morris; P W Thomas; B E Serjeant; G R Serjeant
Journal:  J Pediatr       Date:  1992-03       Impact factor: 4.406

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  Precursors of executive function in infants with sickle cell anemia.

Authors:  Alexandra M Hogan; Paul T Telfer; Fenella J Kirkham; Michelle de Haan
Journal:  J Child Neurol       Date:  2012-08-01       Impact factor: 1.987

View more
  1 in total

Review 1.  Chronic pediatric diseases and risk for reading difficulties: a narrative review with recommendations.

Authors:  Donna Perazzo; Ryan Moore; Nadine A Kasparian; Megan Rodts; Tzipi Horowitz-Kraus; Lori Crosby; Brian Turpin; Andrew F Beck; John Hutton
Journal:  Pediatr Res       Date:  2022-02-04       Impact factor: 3.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.